WCH

Wacker Chemie AG occupies an unusual position in the European materials landscape. Founded in 1914, headquartered in Munich, and still controlled by the Wacker family through Dr. Alexander Wacker Familiengesellschaft mbH, this is a company whose technical capabilities are genuinely world-class. Its four divisions span silicones, polymer binders, biosolutions, and hyperpure polysilicon, each rooted in deep process chemistry that takes decades to master. The company employs roughly 16,655 people and generated EUR 5.49 billion in revenue during fiscal year 2025. On paper, the diversification looks resilient. In practice, it masks a structural vulnerability that the market has only recently begun to price in full.

The central analytical question for Wacker Chemie is not whether the chemistry works. It does. The question is whether a Western-cost-base specialty chemicals company can sustain adequate returns when the single largest driver of its profitability, polysilicon, has been structurally commoditized by Chinese capacity expansion. Fiscal year 2025 answered that question with brutal clarity: a net loss of EUR 821 million, a swing of over EUR 1 billion from the prior year's EUR 241 million profit. This was not a cyclical dip. This was a structural repricing of an entire business line.

The L17X insight here is precise: Wacker Chemie is a company whose technical moat in polysilicon purity is real, verifiable, and increasingly irrelevant to its economics. The ability to produce semiconductor-grade and solar-grade polysilicon at the highest purity levels does not protect margins when Chinese competitors can flood the solar-grade market at prices below Western variable costs. Wacker's polysilicon division, which generated extraordinary profits during the 2021 and 2022 solar boom (contributing to EUR 1.25 billion in net income for FY2022), has become the source of existential financial risk. The company's stock, trading near EUR 90 with a market capitalization of approximately EUR 4.5 billion, reflects a market that has partially but not fully absorbed this structural shift. With next earnings due April 29, 2026, and the most recent quarter (Q1 FY2026) showing EPS of EUR 0.74 against estimates of EUR 1.09, the trajectory remains visibly downward.